Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Pemberton and ADIA raise $1bn for PE NAV lending
Private credit investor Pemberton Asset Management is partnering with the Abu Dhabi Investment Authority to raise at least $1bn to provide net asset value loans to private equity firms, according to a report by Bloomberg. In a statement, Pemberton said that the new...
Eurazeo Sells Stake in MCH Private Equity for €80m Investment in MCH V Fund
French private equity firm Eurazeo has sold its 25% stake in MCH Private Equity, an asset manager specialising in small-cap private equity investments in Spain. As a result of the transaction, which is subject to regulatory approval, Eurazeo retains an €80m...
$50bn AUM New Mountain Capital and Grant Thornton Close Growth Investment Deal
New Mountain Capital, a growth-oriented private investment firm with approximately $50bn in assets under management, has closed a ‘significant’ growth investment in Grant Thornton, a US provider of audit, assurance, tax and advisory services. CDPQ and OA Private...